News from ISGlobal
Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to a patient group-based survey implemented in 25 countries. The Hep-CORE study was coordinated by ISGlobal and led by the European Liver Patient's Association.
In 2016, viral hepatitis caused more deaths than HIV, malaria or tuberculosis. In the European Region, 18 and 15 million people live with chronic HBV and HCV infection, respectively. Due to widespread HBV vaccination, HBV infection is seen more in older Europeans or migrants from countries with high HBV prevalence. Regarding HCV – for which there is no vaccine –transmission is now mainly due to unsafe drug injection practices. New, highly effective direct‐acting antiviral drugs have made HCV much easier and safer to cure, but they are costly and their availability remains a concern.
Jeffrey V Lazarus Samya R Stumo Magdalena Harris, et al.Hep‐CORE: a cross‐sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017. J Int AIDS Soc. 2018 Apr;21 Suppl 2:e25052. doi: 10.1002/jia2.25052.